The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Documenti analoghi

• Risk of Hospitalized COVID ‐19 in COPD : Single‐Inhaler Triple Versus Dual Bronchodilator Therapy
  di: Simon Galmiche, et al.
  Pubblicazione: (2026)
• Masking in Active Comparator Designs in Pharmacovigilance: A Retrospective Bias Analysis on the Spontaneous Reporting of Thiazolidinediones and Cardiovascular Events
  di: William Bai, et al.
  Pubblicazione: (2025)
• The European Drug–Drug Interaction (EuroDDI) Study Protocol: A Cross‐Country Comparison of Drug–Drug Interaction Prevalence in the Older Community‐Dwelling Population
  di: John E. Hughes, et al.
  Pubblicazione: (2025)
• Opioid Use and the Risk of Ventricular Arrhythmias: A Systematic Review and Meta‐Analysis
  di: Shahrzad Salmasi, et al.
  Pubblicazione: (2024)
• A Review of Concordance and Quality in Clinical Guidelines for Hormonal Contraceptives to Mitigate Drug–Drug Interactions in Women With Epilepsy
  di: Matthew R. Muschett, et al.
  Pubblicazione: (2024)